All Outputs (5)

Potential of hybrid iron oxide–gold nanoparticles as thermal triggers for pancreatic cancer therapy (2016)
Journal Article
Oluwasanmi, A., Malekigorji, M., Jones, S., Curtis, A., & Hoskins, C. (2016). Potential of hybrid iron oxide–gold nanoparticles as thermal triggers for pancreatic cancer therapy. RSC advances, https://doi.org/10.1039/c6ra20552f

Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold nanoparticles (HNPs) have shown potential as theranostics due to their ability for imaging using MRI, heating using laser irradiation and carrier abili... Read More about Potential of hybrid iron oxide–gold nanoparticles as thermal triggers for pancreatic cancer therapy.

Synthesis of novel hybrid nanoparticle-prodrug constructs for pancreatic cancer therapy (2016)
Presentation / Conference
Hoskins, C., Curtis, A., & Alfahad, M. (2016, September). Synthesis of novel hybrid nanoparticle-prodrug constructs for pancreatic cancer therapy. Presented at APS PharmSci 2016, Glasgow

Temperature Controlled Theranostics for Pancreatic Cancer (2016)
Presentation / Conference
Malekigorji, M., Kong Thoo Lin, P., Lees, M., Gueorguieva, M., Curtis, A., & Hoskins, C. (2016, September). Temperature Controlled Theranostics for Pancreatic Cancer. Presented at The 7th APS International PharmSci 2016, University of Strathclyde, Glasgow

Novel Iron Oxide-Gold Nanohybrids with Heat Triggered Surface Manipulation (2016)
Presentation / Conference
Curtis, A., Hoskins, C., & Oluwasanmi, A. (2016, September). Novel Iron Oxide-Gold Nanohybrids with Heat Triggered Surface Manipulation. Presented at The 7th APS International PharmSci 2016, University of Strathclyde, Glasgow

Thermoresponsive copolymer: (HPMA-CO-(APMA-R))-co-PEG polymer synthesis and physiochemical characterization (2016)
Presentation / Conference
Hoskins, C., Curtis, A., & Alsuraifi, A. (2016, August). Thermoresponsive copolymer: (HPMA-CO-(APMA-R))-co-PEG polymer synthesis and physiochemical characterization. Presented at British Society of Nanomedicine Early Career Symposium, Swansea